• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

社区获得性呼吸道感染儿童的抗菌药物耐药性(PROTEKT 1999 - 2000)

Antibacterial resistance among children with community-acquired respiratory tract infections (PROTEKT 1999-2000).

作者信息

Felmingham D, Farrell D J, Reinert R R, Morrissey I

机构信息

GR Micro Ltd, London, UK.

出版信息

J Infect. 2004 Jan;48(1):39-55. doi: 10.1016/s0163-4453(03)00140-3.

DOI:10.1016/s0163-4453(03)00140-3
PMID:14667791
Abstract

OBJECTIVE

To determine the susceptibility of bacterial respiratory tract pathogens, isolated from children (0-12 years) as part of the global PROTEKT surveillance study (1999-2000), to a range of antibacterials, including the ketolide telithromycin.

METHODS

Minimum inhibitory concentrations of the antibacterials studied were determined at a central laboratory using the NCCLS microdilution broth method. Macrolide resistance mechanisms were detected by PCR.

RESULTS

Of 779 Streptococcus pneumoniae isolates worldwide, 43% were non-susceptible to penicillin (18% intermediate; 25% resistant) and 37% were resistant to erythromycin, with considerable intercountry variation. Eighteen per cent of 653 Haemophilus influenzae and >90% of 316 Moraxella catarrhalis isolates produced beta-lactamase. Of 640 Streptococcus pyogenes isolates, 10% were resistant to erythromycin, with considerable intercountry variation. All S. pneumoniae and 99.8% of H. influenzae isolates were susceptible to telithromycin using breakpoints proposed to the NCCLS (<or=1 and <or=4 mg/L, respectively). All M. catarrhalis and 97% of S. pyogenes and isolates were susceptible to <or=1 mg/L telithromycin.

CONCLUSIONS

Antibacterial resistance complicates the empirical treatment of respiratory tract infections in children and requires continued monitoring. Telithromycin may be a useful therapeutic alternative as it is highly active against strains exhibiting various resistance phenotypes.

摘要

目的

作为全球PROTEKT监测研究(1999 - 2000年)的一部分,确定从0至12岁儿童中分离出的细菌性呼吸道病原体对包括酮内酯类药物泰利霉素在内的一系列抗菌药物的敏感性。

方法

在一个中心实验室采用美国国家临床实验室标准化委员会(NCCLS)微量稀释肉汤法测定所研究抗菌药物的最低抑菌浓度。通过聚合酶链反应(PCR)检测大环内酯类耐药机制。

结果

在全球779株肺炎链球菌分离株中,43%对青霉素不敏感(18%为中介;25%为耐药),37%对红霉素耐药,国家间差异显著。在653株流感嗜血杆菌分离株中,18%产生β-内酰胺酶,在316株卡他莫拉菌分离株中,>90%产生β-内酰胺酶。在640株化脓性链球菌分离株中,10%对红霉素耐药,国家间差异显著。按照向NCCLS提议的断点(分别为≤1mg/L和≤4mg/L),所有肺炎链球菌和99.8%的流感嗜血杆菌分离株对泰利霉素敏感。所有卡他莫拉菌以及97%的化脓性链球菌分离株对≤1mg/L泰利霉素敏感。

结论

抗菌药物耐药性使儿童呼吸道感染的经验性治疗变得复杂,需要持续监测。泰利霉素可能是一种有用的治疗选择,因为它对表现出各种耐药表型的菌株具有高度活性。

相似文献

1
Antibacterial resistance among children with community-acquired respiratory tract infections (PROTEKT 1999-2000).社区获得性呼吸道感染儿童的抗菌药物耐药性(PROTEKT 1999 - 2000)
J Infect. 2004 Jan;48(1):39-55. doi: 10.1016/s0163-4453(03)00140-3.
2
Evolving resistance patterns in community-acquired respiratory tract pathogens: first results from the PROTEKT global surveillance study. Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin.社区获得性呼吸道病原体不断演变的耐药模式:PROTEKT全球监测研究的初步结果。酮内酯类药物泰利霉素的前瞻性耐药菌追踪与流行病学研究。
J Infect. 2002 Feb;44 Suppl A:3-10.
3
Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Latin America: results from the PROTEKT surveillance study (1999-2000).拉丁美洲患者社区获得性呼吸道病原体的抗菌药物耐药性:PROTEKT监测研究(1999 - 2000年)结果
Braz J Infect Dis. 2003 Feb;7(1):44-61. doi: 10.1590/s1413-86702003000100006.
4
Antimicrobial susceptibility among community-acquired respiratory tract pathogens in the USA: data from PROTEKT US 2000-01.美国社区获得性呼吸道病原体的抗菌药物敏感性:来自2000 - 2001年美国PROTEKT的数据。
J Infect. 2004 Jan;48(1):56-65. doi: 10.1016/s0163-4453(03)00123-3.
5
Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Germany and activity of the Ketolide Telithromycin: results from the PROTEKT surveillance study (1999-2000).从德国患者中分离出的社区获得性呼吸道病原体的抗菌耐药性及酮内酯类药物泰利霉素的活性:PROTEKT监测研究(1999 - 2000年)结果
Chemotherapy. 2004 Jun;50(3):143-51. doi: 10.1159/000077889.
6
Comparative in vitro activity of telithromycin and beta-lactam antimicrobials against community-acquired bacterial respiratory tract pathogens in the United States: findings from the PROTEKT US study, 2000-2001.美国2000 - 2001年PROTEKT US研究中泰利霉素与β-内酰胺类抗菌药物对社区获得性细菌性呼吸道病原体的体外活性比较:研究结果
Clin Ther. 2004 Apr;26(4):522-30. doi: 10.1016/s0149-2918(04)90054-9.
7
Comparative in vitro activity of telithromycin and beta-lactam antimicrobials against bacterial pathogens from community-acquired respiratory tract infections: data from the first year of PROTEKT (1999-2000).泰利霉素与β-内酰胺类抗菌药物对社区获得性呼吸道感染病原菌的体外活性比较:PROTEKT研究第一年(1999 - 2000年)的数据
J Chemother. 2003 Aug;15(4):335-41. doi: 10.1179/joc.2003.15.4.335.
8
Comparative activity of telithromycin against typical community-acquired respiratory pathogens.泰利霉素对典型社区获得性呼吸道病原体的比较活性。
J Antimicrob Chemother. 2003 Sep;52(3):371-4. doi: 10.1093/jac/dkg359. Epub 2003 Jul 29.
9
Global surveillance through PROTEKT: the first year.通过“全球抗微生物药物耐药性监测与应对计划”(PROTEKT)进行的全球监测:第一年
J Chemother. 2002 Jul;14 Suppl 3:9-16. doi: 10.1080/1120009x.2002.11782347.
10
Clinical and bacteriological efficacy of the ketolide telithromycin against isolates of key respiratory pathogens: a pooled analysis of phase III studies.酮内酯类药物泰利霉素对主要呼吸道病原体分离株的临床和细菌学疗效:III期研究的汇总分析
Clin Microbiol Infect. 2004 Jan;10(1):27-36. doi: 10.1111/j.1469-0691.2004.00752.x.

引用本文的文献

1
Use of antibiotics for common illnesses among children aged under 5 years in a rural community in Indonesia: a cross-sectional study.印度尼西亚一个农村社区5岁以下儿童常见疾病抗生素使用情况:一项横断面研究。
Trop Med Health. 2019 Jul 18;47:45. doi: 10.1186/s41182-019-0173-6. eCollection 2019.
2
Molecular Cloning and Docking of Gene Encoding Cysteine Protease With Antibiotic Interaction in NBMKU12 From the Clinical Isolates.临床分离株NBMKU12中编码与抗生素相互作用的半胱氨酸蛋白酶基因的分子克隆与对接
Front Microbiol. 2018 Aug 7;9:1658. doi: 10.3389/fmicb.2018.01658. eCollection 2018.
3
Antimicrobial resistance in bacterial pathogens among hospitalized children with community acquired lower respiratory tract infections in Dongguan, China (2011-2016).
中国东莞社区获得性下呼吸道感染住院儿童细菌病原体的抗菌药物耐药性(2011 - 2016年)
BMC Infect Dis. 2017 Sep 11;17(1):614. doi: 10.1186/s12879-017-2710-4.
4
Description of macrolide-resistant and potential virulent clones of Streptococcus pyogenes causing asymptomatic colonization during 2000-2006 in the Lisbon area.2000-2006 年期间,在里斯本地区,导致无症状定植的酿脓链球菌对大环内酯类药物耐药和潜在毒力克隆的描述。
Eur J Clin Microbiol Infect Dis. 2012 May;31(5):849-57. doi: 10.1007/s10096-011-1384-x. Epub 2011 Oct 21.
5
Diversity of pneumococcal surface protein A (PspA) and relation to sequence typing in Streptococcus pneumoniae causing invasive disease in Chinese children.肺炎链球菌表面蛋白 A(PspA)的多样性及其与引起中国儿童侵袭性疾病的肺炎链球菌序列分型的关系。
Eur J Clin Microbiol Infect Dis. 2012 Mar;31(3):217-23. doi: 10.1007/s10096-011-1296-9. Epub 2011 Jun 4.
6
Comparison of transformation frequencies among selected Streptococcus pneumoniae serotypes.选定的肺炎链球菌血清型之间的转化率比较。
Int J Antimicrob Agents. 2010 Aug;36(2):124-8. doi: 10.1016/j.ijantimicag.2010.03.024. Epub 2010 May 15.
7
Serogroup distribution and antimicrobial resistance of nasopharyngeal isolates of Streptococcus pneumoniae among Beijing children with upper respiratory infections (2000-2005).北京地区上呼吸道感染儿童肺炎链球菌鼻咽分离株的血清型分布及耐药性(2000 - 2005年)
Eur J Clin Microbiol Infect Dis. 2008 Aug;27(8):649-55. doi: 10.1007/s10096-008-0481-y. Epub 2008 Mar 18.
8
Mechanisms, molecular and sero-epidemiology of antimicrobial resistance in bacterial respiratory pathogens isolated from Japanese children.从日本儿童分离出的细菌性呼吸道病原体中抗菌药物耐药性的机制、分子及血清流行病学
Ann Clin Microbiol Antimicrob. 2007 Aug 13;6:7. doi: 10.1186/1476-0711-6-7.
9
Effective treatment strategies for paediatric community-acquired pneumonia.儿童社区获得性肺炎的有效治疗策略
Expert Opin Pharmacother. 2007 Jun;8(8):1091-101. doi: 10.1517/14656566.8.8.1091.
10
Emergence of a unique multiply-antibiotic-resistant Streptococcus pneumoniae serotype 7B clone in Dhaka, Bangladesh.孟加拉国达卡出现一种独特的多重耐药肺炎链球菌7B血清型克隆株。
J Clin Microbiol. 2006 Dec;44(12):4625-7. doi: 10.1128/JCM.01740-06. Epub 2006 Sep 27.